Clinical Trial Update: OCT-based DAPT Cessation in HBR Patients [NA]

View source ↗

Summary

An OCT-guided cessation strategy for dual antiplatelet therapy in high-bleeding-risk patients with coronary artery disease has completed data collection, per th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Snippet

Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | Conditions: High Bleeding Risk Patients, DAPT(Dual Antiplatelet Therapy) | NA | Status: COMPLETED